sparfloxacin has been researched along with Tuberculosis, Drug-Resistant in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carneiro, ZA; de Albuquerque, S; de Oliveira, LP; de Souza, MVN; Guerra, W; Lima, MF; Lopes, CD; Paixão, DA; Pavan, FR; Pivatto, M; Ribeiro, CM; Teixeira, LR | 1 |
| Khaĭmenov, AIa; Khaĭmenova, TIu; Lazareva, IaV; Sokolova, GB | 1 |
| Squire, SB; Vizel, AA; Ziganshina, LE | 1 |
| Bhatia, RS; Sibia, SS | 1 |
| Erbes, R; Lode, H; Lubasch, A; Mauch, H | 1 |
| Arora, VK; Gupta, R; Gupta, S; Singla, R | 1 |
1 review(s) available for sparfloxacin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
2 trial(s) available for sparfloxacin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
[Sparfloxacin in combined therapy for pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Arrhythmias, Cardiac; Dermatitis, Phototoxic; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2008 |
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
3 other study(ies) available for sparfloxacin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis.
Topics: Cell Line, Tumor; Cell Survival; Ciprofloxacin; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Fluoroquinolones; Humans; MCF-7 Cells; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant | 2018 |
Treatment of tuberculosis--role of sparfloxacin?
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Tuberculosis, Multidrug-Resistant | 1999 |
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antitubercular Agents; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |